Site-directed ligand discovery
|
journal
|
August 2000 |
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
|
journal
|
October 2016 |
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|
journal
|
November 2013 |
The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
|
journal
|
June 2010 |
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations
|
journal
|
June 2019 |
Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor
|
journal
|
January 2018 |
Comparison of simple potential functions for simulating liquid water
|
journal
|
July 1983 |
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
|
journal
|
April 2010 |
Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures
|
journal
|
December 2005 |
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
|
journal
|
May 2005 |
Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
|
journal
|
February 1997 |
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
|
journal
|
February 2013 |
Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection: Miniperspective
|
journal
|
September 2017 |
BID: a novel BH3 domain-only death agonist.
|
journal
|
November 1996 |
Allosteric inhibition of antiapoptotic MCL-1
|
journal
|
May 2016 |
Epik: a software program for pK a prediction and protonation state generation for drug-like molecules
|
journal
|
September 2007 |
Hydrogen exchange mass spectrometry for the analysis of protein dynamics
|
journal
|
January 2005 |
Scaling and assessment of data quality
|
journal
|
December 2005 |
Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer
|
journal
|
September 2018 |
Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function
|
journal
|
February 2005 |
Integration, scaling, space-group assignment and post-refinement
|
journal
|
January 2010 |
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
|
journal
|
December 2015 |
BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore
|
journal
|
December 2011 |
Programmed Anuclear Cell Death Delimits Platelet Life Span
|
journal
|
March 2007 |
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|
journal
|
January 2013 |
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
|
journal
|
March 2013 |
Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors
|
journal
|
September 2016 |
Docking Covalent Inhibitors: A Parameter Free Approach To Pose Prediction and Scoring
|
journal
|
June 2014 |
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
|
journal
|
January 1995 |
Overcoming drug resistance by cell-penetrating peptide-mediated delivery of a doxorubicin dimer with high DNA-binding affinity
|
journal
|
April 2017 |
High-Speed and High-Resolution UPLC Separation at Zero Degrees Celsius
|
journal
|
September 2008 |
Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family
|
journal
|
June 2007 |
Probing theα-Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and Analysis
|
journal
|
April 2010 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
Bim: a novel member of the Bcl-2 family that promotes apoptosis
|
journal
|
January 1998 |
Inhibition of Pro-Apoptotic BAX by a Noncanonical Interaction Mechanism
|
journal
|
March 2015 |
A Stapled BID BH3 Helix Directly Binds and Activates BAX
|
journal
|
October 2006 |
Analysis of Protein Conformation and Dynamics by Hydrogen/Deuterium Exchange MS
|
journal
|
October 2009 |
Simple One-Pot Synthesis of Disulfide Fragments for Use in Disulfide-Exchange Screening
|
journal
|
April 2011 |
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
|
journal
|
May 2006 |
Molecular dynamics study of small molecule inhibitors of the Bcl-2 family
|
journal
|
June 2011 |
Crystallization and preliminary X-ray crystallographic analysis of the [NiFe]-hydrogenase maturation factor HypF1 from Ralstonia eutropha H16
|
journal
|
March 2010 |
Canonical dynamics: Equilibrium phase-space distributions
|
journal
|
March 1985 |
MOMP, cell suicide as a BCL-2 family business
|
journal
|
October 2017 |
High expression of Bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia
|
journal
|
January 2004 |
A smooth particle mesh Ewald method
|
journal
|
November 1995 |
Constant pressure molecular dynamics algorithms
|
journal
|
September 1994 |
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma
|
journal
|
April 2010 |
BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis
|
journal
|
September 2001 |
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|
journal
|
May 2008 |
Phaser crystallographic software
|
journal
|
July 2007 |